{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "15860430", "DateCompleted": {"Year": "2005", "Month": "06", "Day": "22"}, "DateRevised": {"Year": "2015", "Month": "06", "Day": "15"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1369-5266", "JournalIssue": {"Volume": "8", "Issue": "3", "PubDate": {"Year": "2005", "Month": "Jun"}}, "Title": "Current opinion in plant biology", "ISOAbbreviation": "Curr Opin Plant Biol"}, "ArticleTitle": "Current progress in the use of traditional medicines and nutraceuticals.", "Pagination": {"StartPage": "324", "EndPage": "328", "MedlinePgn": "324-8"}, "Abstract": {"AbstractText": ["Traditional medicines in the form of botanical dietary supplements and nutraceuticals have found a place in 21st century healthcare. They nonetheless all contain compounds that are foreign to humans (i.e. xenobiotics) and that are subject to the same pharmacological issues encountered by synthetic therapeutic agents. It is crucial therefore for all parties, the medical profession, investigative scientists, the regulatory agencies and the public, to understand the particular characteristics of botanicals and nutraceuticals and their potential for success and failure in preventing and confronting disease."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, McCallum Research Building, University of Alabama at Birmingham, 1918 University Boulevard, Birmingham, Alabama 35294, USA. sbarnes@uab.edu"}], "Identifier": [], "LastName": "Barnes", "ForeName": "Stephen", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Prasain", "ForeName": "Jeevan", "Initials": "J"}], "GrantList": [{"GrantID": "P50 AT00477", "Acronym": "AT", "Agency": "NCCIH NIH HHS", "Country": "United States"}, {"GrantID": "U54 CA100949", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S.", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Curr Opin Plant Biol", "NlmUniqueID": "100883395", "ISSNLinking": "1369-5266"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Dietary Supplements"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism", "toxicity"], "DescriptorName": "Plants, Medicinal"}], "NumberOfReferences": "41"}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2005", "Month": "4", "Day": "30", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "6", "Day": "23", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "4", "Day": "30", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["15860430", "10.1016/j.pbi.2005.03.010", "S1369-5266(05)00042-7"]}}], "PubmedBookArticle": []}